Study of an experimental drug for lung cancer with fluid in the chest
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new drug given directly into the chest cavity to treat fluid buildup caused by non-small cell lung cancer. It may help ease breathing problems and control the fluid.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have non-small cell lung cancer that has spread to the lining of the chest, causing fluid buildup.
- You have trouble breathing because of the fluid.
- You have not had any local treatment in your chest, like drugs or radiation, in the past month.
- You are generally able to care for yourself (ECOG score 0-2) and expected to live at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug called JMKX000197 given into the chest to control fluid buildup caused by cancer. It is for people with advanced solid tumors that have led to a moderate or large pleural effusion requiring drainage.
This study tests a new injectable drug called JMKX000197 compared to cisplatin (a standard chemotherapy) to treat fluid buildup around the lungs caused by advanced cancer. The goal is to see if the new drug works as well as or better than cisplatin with fewer side effects.
This study collects fluid that builds up around your lungs (pleural effusion) during a drainage procedure you already need. Researchers test how different drugs affect your cancer cells in the lab to help predict which treatments might work best for you.
This study tests whether a thin, flexible tube (like a small camera) can safely and effectively help doctors get tissue samples from fluid around the lung. It compares a single-use flexible tool to a standard semi-rigid scope, and may help find the cause of your lung fluid.
This trial tests a procedure called pleural manometry, which measures pressure in the chest during fluid drainage, to see if it helps doctors better assess and treat malignant pleural effusion (fluid buildup around the lung caused by cancer). The goal is to improve symptom relief and treatment decisions.
This study compares two ways to manage fluid buildup around the lung from cancer: placing a tube to drain it or using a procedure (pleurodesis) to seal the space and prevent fluid from returning. The goal is to find which method provides better comfort and relief.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.